Eric Grouzmann

6.9k total citations
168 papers, 5.5k citations indexed

About

Eric Grouzmann is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Surgery. According to data from OpenAlex, Eric Grouzmann has authored 168 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cellular and Molecular Neuroscience, 54 papers in Molecular Biology and 46 papers in Surgery. Recurrent topics in Eric Grouzmann's work include Neuropeptides and Animal Physiology (73 papers), Receptor Mechanisms and Signaling (38 papers) and Adrenal and Paraganglionic Tumors (29 papers). Eric Grouzmann is often cited by papers focused on Neuropeptides and Animal Physiology (73 papers), Receptor Mechanisms and Signaling (38 papers) and Adrenal and Paraganglionic Tumors (29 papers). Eric Grouzmann collaborates with scholars based in Switzerland, United States and Portugal. Eric Grouzmann's co-authors include Cláudia Cavadas, Hans R. Brunner, Thierry Pedrazzini, Matthias E. Liechti, Bernard Waeber, François Pralong, Jean-François Aubert, Linda D. Simmler, Yasmin Schmid and Massimiliano Donzelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Eric Grouzmann

165 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Grouzmann Switzerland 42 2.5k 1.5k 838 795 788 168 5.5k
Heide Hörtnagl Austria 49 2.7k 1.1× 2.3k 1.5× 755 0.9× 506 0.6× 409 0.5× 127 7.8k
Weihong Pan United States 54 2.1k 0.8× 2.3k 1.5× 555 0.7× 593 0.7× 2.5k 3.2× 181 9.6k
Robert H. Lipsky United States 44 2.5k 1.0× 2.6k 1.7× 311 0.4× 278 0.3× 232 0.3× 112 8.1k
Takeo Yoshikawa Japan 59 2.2k 0.9× 5.0k 3.2× 986 1.2× 377 0.5× 318 0.4× 353 11.1k
Markus Schwaninger Germany 60 1.7k 0.7× 4.1k 2.7× 659 0.8× 714 0.9× 859 1.1× 217 12.3k
Diego J. Walther Germany 21 1.2k 0.5× 1.5k 1.0× 658 0.8× 322 0.4× 269 0.3× 30 4.9k
Takayuki Nakagawa Japan 45 2.1k 0.8× 1.9k 1.3× 533 0.6× 628 0.8× 268 0.3× 246 7.1k
Christoffer Clemmensen Denmark 32 762 0.3× 1.6k 1.1× 1.2k 1.4× 1.5k 1.9× 798 1.0× 88 5.2k
David Vaudry France 46 5.5k 2.2× 4.9k 3.2× 1.2k 1.5× 672 0.8× 737 0.9× 193 9.4k
Lennart Svensson Sweden 41 2.0k 0.8× 1.7k 1.1× 318 0.4× 564 0.7× 1.2k 1.5× 115 5.3k

Countries citing papers authored by Eric Grouzmann

Since Specialization
Citations

This map shows the geographic impact of Eric Grouzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Grouzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Grouzmann more than expected).

Fields of papers citing papers by Eric Grouzmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Grouzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Grouzmann. The network helps show where Eric Grouzmann may publish in the future.

Co-authorship network of co-authors of Eric Grouzmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Grouzmann. A scholar is included among the top collaborators of Eric Grouzmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Grouzmann. Eric Grouzmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eugster, Philippe J., Jason Oke, Brian D Nicholson, et al.. (2024). Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection. European Urology Open Science. 66. 12–15.
2.
Mansi, Rosalba, Raghuvir H. Gaonkar, Melpomeni Fani, et al.. (2023). CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors. Journal of Translational Medicine. 21(1). 604–604. 3 indexed citations
3.
Herzig, David, Gemma Reverter‐Branchat, Michele Schiavon, et al.. (2023). Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals. Diabetologia. 66(4). 741–753. 10 indexed citations
4.
Eugster, Philippe J., Karim Abid, Maurice Matter, et al.. (2022). Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma. Clinica Chimica Acta. 534. 146–155. 6 indexed citations
5.
Peitzsch, Mirko, Denise Kaden, Max Kurlbaum, et al.. (2021). Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine. Clinical Chemistry. 67(8). 1098–1112. 21 indexed citations
6.
Harris, Alan G., et al.. (2018). Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors. Neuropeptides. 68. 84–89. 8 indexed citations
7.
Gerber, Vinzenz, et al.. (2016). Catecholamine Metabolism in a Shetland Pony with Suspected Pheochromocytoma and Pituitary Pars Intermedia Dysfunction. Journal of Veterinary Internal Medicine. 30(6). 1872–1878. 6 indexed citations
8.
Schmid, Yasmin, Anna Rickli, Urs Duthaler, et al.. (2015). Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects. Journal of Pharmacology and Experimental Therapeutics. 353(1). 102–111. 44 indexed citations
9.
Grouzmann, Eric, Maurice Matter, Stefan Bilz, et al.. (2012). Monoamine Oxidase A Down-Regulation Contributes to High Metanephrine Concentration in Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 97(8). 2773–2781. 22 indexed citations
10.
Schmid, Yasmin, et al.. (2012). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. British Journal of Pharmacology. 166(8). 2277–2288. 56 indexed citations
11.
Hysek, Cédric M., Linda D. Simmler, Massimiliano Donzelli, et al.. (2012). Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study. PLoS ONE. 7(5). e36476–e36476. 133 indexed citations
12.
Grouzmann, Eric, et al.. (2008). Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema. Commentary. Hypertension. 51(1). 1 indexed citations
13.
Pedrazzini, Thierry, François Pralong, & Eric Grouzmann. (2003). Neuropeptide Y: the universal soldier. Cellular and Molecular Life Sciences. 60(2). 350–377. 218 indexed citations
14.
Grouzmann, Eric, et al.. (2003). Semisynthesis and Characterization of the First Analogues of Pro‐Neuropeptide Y. ChemBioChem. 4(5). 425–433. 18 indexed citations
15.
Shay, Neil F., et al.. (2002). Zinc Status Affects Neurotransmitter Activity in the Paraventricular Nucleus of Rats. Journal of Nutrition. 132(2). 270–275. 20 indexed citations
16.
Cavadas, Cláudia, François Mosimann, Maria Dulce Cotrim, et al.. (2001). NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells. The Journal of Clinical Endocrinology & Metabolism. 86(12). 5956–5963. 62 indexed citations
17.
Lo, Ming, et al.. (1999). The subtype 2 of angiotensin II receptors and pressure‐natriuresis in adult rat kidneys. British Journal of Pharmacology. 126(3). 826–832. 24 indexed citations
18.
Grouzmann, Eric, et al.. (1997). Characterization of a Selective Antagonist of Neuropeptide Y at the Y2 Receptor. Journal of Biological Chemistry. 272(12). 7699–7706. 51 indexed citations
19.
Plouin, P F, Jérôme Bertherat, Eliane M. Billaud, et al.. (1995). Short‐term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo‐controlled trial. Clinical Endocrinology. 42(3). 289–294. 38 indexed citations
20.
Grouzmann, Eric, E Comoy, Philippe Walker, et al.. (1992). Production and Characterization of Four Anti-Neuropeptide Y Monoclonal Antibodies. Hybridoma. 11(4). 409–424. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heide Hörtnagl Breakdown of academic impact, for papers by Weihong Pan Breakdown of academic impact, for papers by Robert H. Lipsky Breakdown of academic impact, for papers by Takeo Yoshikawa Breakdown of academic impact, for papers by Markus Schwaninger Breakdown of academic impact, for papers by Diego J. Walther Breakdown of academic impact, for papers by Takayuki Nakagawa Breakdown of academic impact, for papers by Christoffer Clemmensen Breakdown of academic impact, for papers by David Vaudry Breakdown of academic impact, for papers by Lennart Svensson
Rankless by CCL
2026